Entering text into the input field will update the search result below

Vaccine And Stimulus Optimism Lifts Market Sentiment

Dec. 02, 2020 3:42 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Equities rose, while the US dollar and the Japanese yen slid on Tuesday, as investors turned their attention back to developments surrounding a potential COVID-19 vaccine.
  • What may have also lifted sentiment is the testimony of Fed Chief Powell and Treasury Secretary Mnuchin, where the two officials agreed on more support for small businesses.
  • On top of that, a group of US Congress members proposed a virus relief package in a bid to pass it sometime this month.

Original Source

Equities Gain, USD Slides on Vaccine and Stimulus Hopes

The US dollar traded lower against all but two of the other G10 currencies on Tuesday and during the Asian session Wednesday. It lost the most ground against EUR, SEK, and CHF in that order, while it was found virtually unchanged versus AUD and JPY.

USD performance G10 currencies

The weakening of the US dollar and the Japanese yen suggests that financial markets traded in a risk-on fashion. However, the strengthening of the Swiss franc and the weakening of the Aussie point otherwise. Thus, in order to get a clearer picture with regards to the broader market sentiment, we prefer to turn our gaze to the equity world. There, major EU and US indices were a sea of green, with the S&P 500 and Nasdaq hitting fresh record highs. That said, investors’ morale softened during the Asian session today. Although South Korea’s KOSPI gained 1.58%, Japan’s Nikkei 225, China’s Shanghai Composite and Hong Kong’s Hang Seng traded virtually unchanged.

Major global stock indices performance

It seems that following Monday’s profit taking and portfolio rebalancing, market participants turned their attention back to the positive developments over a potential coronavirus drug. Pfizer and BioNTech have already sought emergency approval from the European regulator of their vaccine candidate, while Moderna announced that it would also ask for conditional approval.

Apart from vaccine hopes, what may have also fueled market sentiment is the testimony of Fed Chair Powell and Treasury Secretary Steven Mnuchin before the Senate Banking Committee. Both officials agreed to provide more help for small businesses as the economic relief following the distribution of a vaccine may not arrive in time to keep them from failing. Although Democrats said that Mnuchin’s decision to shut Fed’s emergency lending programs seemed to contradict his call for help, Powell agreed that at this point businesses may need outright grants from the government, instead of piling on more debt. He also agreed that a separate Treasury fund could be used by the incoming administration of President-elect Joe Biden to re-establish the Fed lending programs if they are needed.

On top of that, Mnuchin held talks with House Speaker Nancy Pelosi over a potential fiscal aid, while a bipartisan group of senators and House members proposed a USD 908bn worth of coronavirus relief package, in a bid to pass a bill sometime this month. US Senate leader Mitch McConnell also raised the importance of including a fresh wave of coronavirus stimulus in a must-pass spending bill aimed at avoiding a government shutdown in the midst of the pandemic.

All this are in line with our view. Remember that yesterday, despite Monday’s setback in equities, we remained positive over the broader market sentiment. We based our view on the positive developments surrounding a potential coronavirus vaccine, while headlines pointing to more fiscal and monetary policy support add more credence. We stick to our guns that equities and other risk-linked assets are likely to continue marching north, while safe-havens, the likes of the US dollar and the Japanese yen, could stay under selling interest.

Euro Stoxx 50 – Technical Outlook

Euro Stoxx 50 continues to balance above a short-term upside support line taken from the low of November 9th, but at the same time it struggles to overcome the 3538 resistance barrier, which is the highest point of November. For now, we will take a somewhat positive approach, because in order to get comfortable with the upside idea, we need to see a push above the 3538 zone first.

If, eventually, the index does move and stay above that 3538 zone, this will confirm a forthcoming higher high, possibly clearing the path to some higher resistance areas, where one of those could be at 3597. That hurdle is marked by the high of February 26th. That said, if the buyers see that hurdle only as a temporary obstacle on the way higher, its break might open the door for a push to the 3676 level, marked by the high of February 25th.

Alternatively, if the aforementioned upside line breaks and the price falls below the low of November 30th, at 3476, that could attract a few more sellers into the game. Euro Stoxx 50 might then drift to the 3438 zone, a break of which may set the stage for a test of the 3395 and 3380 levels. Those levels are marked by the low of November 12th and an intraday swing low of November 9th respectively.

GBP/USD – Technical Outlook

Yesterday, we finally saw GBP/USD breaking and staying above the psychological 1.3400 area. This move could be seen as a positive one, as it increases the pair’s chances for a further move north and more buyers may join in if the rate will remain above that 1.3400 zone. For now, we will take a positive approach.

This morning we are seeing a small correction lower, however, if the pair stays above that 1.3400 area, the buyers could step in and drive GBP/USD to the next potential resistance hurdle, at 1.3482. That hurdle is marked by the highest point of September, which might temporarily halt the upmove. That said, if the buyers are still feeling a bit more comfortable than the bears, a break of that 1.3482 zone may lead GBP/USD to the 1.3514 level, marked by the highest point of December 2019.

In order to consider a short-term bearish reversal, we would prefer to wait for a violation of a short-term upside support line drawn from the low of November 13th and then a drop below the 1.3288 hurdle, marked by the low of November 27th. All that could strengthen the bearish case and send the pair further south. It might then drift below the 1.3263 obstacle and target the 1.3195 zone, marked by the low of November 19th, which coincides with the 200 EMA on our 4-hour chart. GBP/USD may even rebound somewhat, however, if the pair stays somewhere below the 1.3288 barrier, another slide might be possible. If this time GBP/USD is able to move below the 1.3195 hurdle, the next obstacle on the way lower could be at 1.3165, a break of which may clear the way towards the 1.3106 level, marked by the low of November 12th.

As for Today’s Events

In the US, besides the second round of Powell’s and Mnuchin’s testimony, we also have the ADP employment report for November. The private sector is forecast to have gained 400k jobs, after adding 365k in October. This could raise speculation that the NFP print, due out on Friday, may also exceed October’s number, which was at 638k. That said, as we noted several times in the past, the ADP print is far from a reliable predictor of where the NFPs may come in. Even last month, when the ADP slowed to around half (to 365k from 749k), NFPs stayed close to their September figure (638k vs 672k).

The EIA weekly report on crude oil inventories is due to be released as well, with the forecast pointing to a 2.358mn barrels fall after a 0.754mn slide the week before. That said, bearing in mind that the API report revealed a 4.146mn barrels increase, we would consider the risks surrounding the EIA report as tilted to the upside. In any case, this week, oil traders are likely to keep their gaze locked on the outcome of the OPEC+ meeting, where members will decide whether to increase production, or extend the existing curbs.

As for the speakers, apart from Powell and Mnuchin, we have four more on the agenda. Those are Fed Board Governor Randal Quarles, New York Fed President John Williams, ECB Chief Economist Philip Lane, and BoE MPC member Jonathan Haskel.

Analyst's Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

The content we produce does not constitute investment advice or investment recommendation (should not be considered as such) and does not in any way constitute an invitation to acquire any financial instrument or product. The Group of Companies of JFD, its affiliates, agents, directors, officers or employees are not liable for any damages that may be caused by individual comments or statements by JFD analysts and assumes no liability with respect to the completeness and correctness of the content presented. The investor is solely responsible for the risk of his investment decisions. Accordingly, you should seek, if you consider appropriate, relevant independent professional advice on the investment considered. The analyses and comments presented do not include any consideration of your personal investment objectives, financial circumstances or needs. The content has not been prepared in accordance with the legal requirements for financial analyses and must therefore be viewed by the reader as marketing information. JFD prohibits the duplication or publication without explicit approval. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 72.57% of the retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.